These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Policy implications of oral agents. Spoelstra SL; Given BA; Given CW; Grant M Semin Oncol Nurs; 2011 May; 27(2):161-5. PubMed ID: 21514485 [TBL] [Abstract][Full Text] [Related]
3. There's many a slip twixt cup and lip: adherence issues in cancer therapy. Fallowfield L Nat Clin Pract Oncol; 2008 Mar; 5(3):118-9. PubMed ID: 18212767 [No Abstract] [Full Text] [Related]
4. Assessment and measurement of adherence to oral antineoplastic agents. Spoelstra SL; Given CW Semin Oncol Nurs; 2011 May; 27(2):116-32. PubMed ID: 21514481 [TBL] [Abstract][Full Text] [Related]
9. Oral cancer chemotherapy: the promise and the pitfalls. McLeod HL; Evans WE Clin Cancer Res; 1999 Oct; 5(10):2669-71. PubMed ID: 10537326 [No Abstract] [Full Text] [Related]
11. Oral agents in cancer treatment: the context for adherence. Barton D Semin Oncol Nurs; 2011 May; 27(2):104-15. PubMed ID: 21514480 [TBL] [Abstract][Full Text] [Related]
13. Promises and pitfalls of oral cancer chemotherapy. Ergolin MJ Clin Adv Hematol Oncol; 2009 Feb; 7(2):S8-10. PubMed ID: 19391311 [No Abstract] [Full Text] [Related]
14. Administration of cytotoxic drugs. Speechley V Nurs Mirror; 1984 Jan; 158(2):22-5. PubMed ID: 6559346 [No Abstract] [Full Text] [Related]
15. Prescription drugs: uses and effects. Jordan S; Knight J; Jones J Nurs Stand; 2005 Mar 16-22; 19(27):2 p following 56. PubMed ID: 15793970 [No Abstract] [Full Text] [Related]